relapsed

  1. T

    Encouraging Phase 2 Interim Data For Elotuzumab In Relapsed Multiple Myeloma Presente

    Abbott (NYSE: ABT) and Bristol-Myers Squibb Company (NYSE: BMY) announced interim results from the Phase 2 portion of a Phase 1b/2 open-label study which showed a high objective response rate (ORR) among patients with relapsed multiple myeloma who received elotuzumab plus lenalidomide and...
  2. T

    New Drug Achieves 34% Remission In Relapsed Or Refractory Hodgkin Lymphoma Patients

    Experimental drug Brentuximab Vedotin (SGN-35) achieved tumor volume reductions in 94% of Relapsed or Refractory Hodgkin Lymphoma patients while 34% of them achieved complete remission, Seattle Genetics reported after completing a Pivotal Clinical Trial. The company expects to submit the...
  3. T

    Oncolytics Biotech® Inc. Announces Phase I Study In Pediatric Patients With Relapsed

    Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ: ONCY) announced that the Children's Oncology Group (COG) intends to conduct a Phase I trial of REOLYSIN® in combination with cyclophosphamide in pediatric patients with relapsed or refractory solid tumors. The study will be conducted in...
  4. T

    Micromet's Blinatumomab Induces Durable Remissions In Patients With Relapsed Non-Hodg

    Micromet, Inc. (Nasdaq: MITI) announced the presentation of updated results from a Phase 1 trial of the Company's lead product candidate blinatumomab (MT103) in patients with relapsed non-Hodgkin's lymphoma (NHL). A high objective response rate was maintained among patients treated with...
  5. Fred

    why have i suddenly relapsed back into my depression and anxiety - HOW!!!!! WHY!!!?

    ok i have been on my new medication about 6-7 week (i was refered to crisis unit and they sorted me out and got my life turned around) , before that i was bad , having panic attacks , days seeming like weeks , throwing up , shaking , not wanting to see anyone so anyway , i know all these...
Back
Top